ELYBRIO
Live / Applied — Fifth extension granted (statement of use) (as of 16 Mar 2026)
What this means for you
Not registered yet, but its 25 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97285540
- Mark type
- Stylized text
- Filed
- 25 Feb 2022
- Published for opposition
- 01 Nov 2022
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 16 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2026 — SOU EXTENSION 5 GRANTED
- 14 Oct 2025 — SOU EXTENSION 5 FILED
- 13 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2025 — SOU EXTENSION 4 GRANTED
- 31 Mar 2025 — SOU EXTENSION 4 FILED
- 31 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED